Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences Revenue

Arcus Biosciences had revenue of $41.00M in the quarter ending June 30, 2026, a decrease of -74.38%. This brings the company's revenue in the last twelve months to $117.00M, down -55.34% year-over-year. In the year 2025, Arcus Biosciences had annual revenue of $247.00M, down -4.26%.

• Revenue (ttm): $117.00M
• Revenue Growth: -55.34%
• P/S Ratio: 30.11
• Revenue / Employee: $194,676
• Employees: 601
• Market Cap: 3.37B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	247.00M	-11.00M	-4.26%
Dec 31, 2024	258.00M	141.00M	120.51%
Dec 31, 2023	117.00M	5.00M	4.46%
Dec 31, 2022	112.00M	-271.00M	-70.76%
Dec 31, 2021	383.00M	305.00M	391.03%
Dec 31, 2020	78.00M	63.00M	420.00%
Dec 31, 2019	15.00M	6.65M	79.58%
Dec 31, 2018	8.35M	6.94M	491.15%
Dec 31, 2017	1.41M	-	-
Dec 31, 2016	-	-	-

Data Source: Fiscal.ai Last updated: Aug 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 21, 2026

Data Sources Report a data error